Advaxis, Inc. (NASDAQ: ADXS) is a clinical-stage biotechnology company focusing on development of multiple cancer immunotherapies based on its proprietary cancer-fighting platform. The company has created and is developing more than 20 immunotherapies based on its platform, either directly or through collaboration. The company is currently conducting clinical trials with its leading product candidate, ADXS-HPV, in HPV-associated cervical cancer, head and neck cancer and anal cancer. For more information, visit the company’s website at www.advaxis.com.

Noble Financial Capital Markets, an equity research driven, full-service, investment banking boutique, is hosting its tenth annual equity conference in Sandpiper Bay, FL. Attended by institutional investors from across North America, the event features more than 140 public company executive teams from a diverse range of industries. For more information, visit www.noble.missionir.com.